VEEVNEUTRAL

VEEV Return on Equity (ROE) Analysis

13.9%

Higher than 60% of Healthcare sector peers

Updated 97h ago·SEC filings & market data

Key Takeaway

Return on Equity (ROE) measures how effectively a company generates profit from its shareholders’ equity — a 13.9% ROE means Veeva earned $0.139 for every dollar of equity.

Sector Performance

60th percentile

VEEV

13.9%

Sector Median

8.9%

Sector Avg

37.1%

Prior Period

12.6%(May 2026)

↑ Improving

📊

Deep Analysis

Return on Equity (ROE) measures how effectively a company generates profit from its shareholders’ equity — a 13.9% ROE means Veeva earned $0.139 for every dollar of equity.

This figure ranks above the Healthcare sector median of 8.9% and places Veeva in the 60th percentile among its sector peers. There is no trend data available: the year-over-year change, quarter-over-quarter change, and trend over the last eight quarters are all reported as N/A. Without a trend, you cannot assess whether this ROE is improving or deteriorating, leaving the future direction uncertain. The combination of a level above the sector median but with no trend creates a neutral risk-opportunity profile — the current efficiency is acceptable, but there is no evidence of momentum. This metric supports the overall NEUTRAL verdict because the above-median ROE is a positive, but the lack of trend data prevents a stronger bullish or bearish tilt.

Frequently Asked Questions

What does the Return on Equity (ROE) tell investors about VEEV?

ROE measures how effectively management turns equity into profit. Consistently above 15% is typically considered strong. Negative equity distorts this metric.

How is the Return on Equity (ROE) calculated?

Return on Equity (ROE) is calculated as: Net Income / Shareholders' Equity.

How does VEEV's Return on Equity (ROE) compare to its sector?

VEEV's Return on Equity (ROE) of 13.9% compares to a Healthcare sector median of 8.9%, placing it in the 60th percentile.

Who are VEEV's closest peers by Return on Equity (ROE)?

The closest Healthcare peers by Return on Equity (ROE) include: BIIB (7.7%), TECH (5.3%), TMO (13.5%), REGN (14.5%), RVTY (3.2%).

📚

Learn More About Return on Equity (ROE)

What Is Return on Equity (ROE) and Is Higher Always Better?

Return on equity ROE measures how efficiently a company generates profit from shareholder capital. Learn how to decompose ROE using DuPont analysis and why high leverage can make it dangerous—with Apple and JPMorgan examples.

The Formula

Net Income / Shareholders' Equity

Why It Matters

ROE measures how effectively management turns equity into profit. Consistently above 15% is typically considered strong. Negative equity distorts this metric.